Recombinant Mycoplasma pneumoniae Putative type-1 restriction enzyme specificity protein MPN_285 (MPN_285)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
MPN_285; A65_orf306; MP550; Putative type-1 restriction enzyme specificity protein MPN_285; S.MpnORFGP; Type I restriction enzyme specificity protein MPN_285; S protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-306
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_285
Target Protein Sequence
MAEIPIDFPP LKIQEKIATI LDTFTELSAE LSAELSAELS AELSAELSAE LSAELSAELS AELSAELSAE LSAELSAELS AELSAELRER RKQYAFYRDY LLNQENIRKI YGANIPFETF QIRDICEINR GREINEKYLR ENPGEFPVYS SATTNGGLIG KINDYDFHGE YVTWTTGGAH AGNVFYRNEK FSCSQNCGLL EVKNKNKFSS KFLCFALKLQ SKKFVNYASA IPVLTIKRIA EIELSFPPLE IQEKIADILF AFEKLCNDLT EGIPAEIELR KKQLDYYQNF LFNWVQNKKL ESLKSL
Uniprot No.

Target Background

Function
The M and S subunits form a methyltransferase (MTase) that methylates two adenine residues in complementary strands of a bipartite DNA recognition sequence. Subunit S determines DNA sequence specificity.
Protein Families
Type-I restriction system S methylase family

Q&A

What is MPN_285 and what is its role in Mycoplasma pneumoniae?

MPN_285 is a gene in Mycoplasma pneumoniae that encodes a specificity subunit S (HsdS) of the Type I restriction-modification (R-M) system. Located at position 340,244-341,533 bp in the reference strain M129, this gene produces a protein that is involved in the recognition of specific DNA sequences for restriction and modification activities. The Type I R-M system plays a crucial role in protecting bacteria from foreign DNA by discriminating between self and non-self DNA, thereby contributing to the bacterial defense mechanisms against bacteriophages and other invading genetic elements .

The protein's specific function involves determining the DNA sequence specificity of the Type I R-M complex, which consists of restriction (R), modification (M), and specificity (S) subunits. The S subunit (MPN_285) is particularly important as it guides the complex to specific recognition sequences in the DNA, where the complex either restricts (cleaves) or modifies (methylates) the DNA depending on its methylation status .

How does the structure of MPN_285 differ between macrolide-susceptible and macrolide-resistant strains?

The structure of MPN_285 shows distinct patterns between macrolide-susceptible and macrolide-resistant strains, primarily in the number of tandem repeats. The length of the mpn285 gene ranges from 1254 to 1446 base pairs (bp), with the reference strain M129 having a length of 1290 bp .

Key structural differences include:

  • Macrolide-susceptible strains (including the M129 reference strain) have deletions of "TELS" tandem repeats that are not observed in macrolide-resistant strains .

  • The gene length in macrolide-susceptible strains (1254-1374 bp) is generally shorter than in macrolide-resistant strains (commonly 1446 bp) .

  • The number of "TELS" tandem repeat deletions in susceptible strains ranges from six (in strain 11-473) to sixteen (in strains 11-107 and 11-994) .

  • Threonine to alanine amino acid changes, resulting from adenine to guanine SNP changes, are scattered around the tandem repeat regions .

These structural differences make MPN_285 a potential marker for distinguishing between macrolide-susceptible and macrolide-resistant strains of M. pneumoniae.

What experimental approaches can be used to study the functional implications of MPN_285 tandem repeat variations?

To study the functional implications of MPN_285 tandem repeat variations, researchers can implement several methodological approaches:

  • Gene Inactivation Studies: Utilizing techniques similar to those employed for glpQ in M. pneumoniae (as demonstrated in search result ), researchers can generate targeted gene disruptions in MPN_285. This involves:

    • Creating a suitable plasmid construct containing portions of the MPN_285 gene

    • Introducing antibiotic resistance markers for selection

    • Transforming M. pneumoniae cells with the construct

    • Selecting transformants on appropriate media

    • Confirming gene disruption through PCR and sequencing

  • Comparative Genomics Analysis: Researchers should perform whole genome sequencing (WGS) of multiple strains with varying tandem repeat numbers to establish clear correlations between repeat patterns and phenotypes. This approach requires:

    • Sequencing multiple M. pneumoniae isolates with known macrolide susceptibility profiles

    • Aligning sequences to identify variant sites

    • Focusing specifically on tandem repeat regions in MPN_285

    • Correlating variations with resistance patterns

  • Protein Expression and Purification: Expressing recombinant versions of MPN_285 with different tandem repeat numbers to study biochemical properties:

    • Cloning MPN_285 variants into expression vectors

    • Expressing in suitable host systems (E. coli or other expression systems)

    • Purifying using affinity chromatography

    • Comparing enzymatic activities and binding properties of different variants

  • Site-Directed Mutagenesis: Creating specific mutations to evaluate the importance of individual amino acids or repeat units:

    • Designing primers to introduce/remove specific tandem repeats

    • Generating mutants with varying numbers of repeats

    • Evaluating the effect on protein function and macrolide resistance

How do tandem repeat variations in MPN_285 correlate with antibiotic resistance?

The correlation between MPN_285 tandem repeat variations and macrolide resistance in M. pneumoniae is significant and follows specific patterns:

  • Repeat Pattern Differences: Macrolide-resistant strains consistently maintain complete "TELS" tandem repeats, while susceptible strains show deletions of these repeats. This creates a longer gene product in resistant strains (commonly 1446 bp) compared to susceptible strains (ranging from 1254 to 1374 bp) .

  • Quantitative Correlation: The number of tandem repeat deletions appears to correlate with the degree of susceptibility. Macrolide-susceptible strains show deletion numbers ranging from 6 to 16 repeat units, establishing a potential "dose-response" relationship .

  • Consistency Across Strains: Among the 20 sequence type 3 (ST3) M. pneumoniae strains analyzed, the association between tandem repeat patterns and macrolide resistance was consistent, suggesting this is not a random association but likely functionally significant .

This correlation suggests that MPN_285 tandem repeat variations could serve as molecular markers for macrolide resistance and may have functional implications in the mechanism of resistance. The highly conserved nature of these variations (>99.99% genetic similarity within ST3 strains) further emphasizes their potential biological significance .

What is the relationship between MPN_285 and other proteins in the Type I restriction-modification system?

The relationship between MPN_285 and other components of the Type I restriction-modification system involves:

  • Functional Cooperation: MPN_285 functions as a specificity subunit (HsdS) that works in concert with restriction (HsdR) and modification (HsdM) subunits to form a complete Type I R-M complex. This complex has both restriction endonuclease and methyltransferase activities .

  • Synergy with Other HsdS Proteins: M. pneumoniae possesses multiple HsdS genes (with ten currently known), including MPN_085 (also referenced as mpn089), which also shows tandem repeat variations associated with macrolide resistance. These multiple specificity subunits likely allow the bacterium to recognize and respond to different DNA sequences .

  • Complementary Roles: Research indicates that resistance-related tandem repeat patterns appear in both MPN_285 and MPN_085 simultaneously in resistant strains. The "ELSA" tandem repeats in MPN_085 and "TELS" repeats in MPN_285 both show distinct patterns between susceptible and resistant strains, suggesting coordinated evolution or functional complementarity .

  • System-wide Impact: Changes in the specificity subunits like MPN_285 potentially alter the entire R-M system's functionality, affecting how M. pneumoniae responds to foreign DNA and potentially influencing horizontal gene transfer and genomic stability .

What techniques are most effective for isolating and characterizing MPN_285 in laboratory settings?

For effective isolation and characterization of MPN_285, researchers should employ these methodological approaches:

  • Genomic DNA Extraction and PCR Amplification:

    • Use specialized extraction kits designed for mycoplasmas, which have minimal DNA content

    • Design primers specific to conserved regions flanking the MPN_285 gene

    • Employ high-fidelity polymerase to accurately capture tandem repeat regions

    • Consider long-read sequencing technologies to accurately resolve repeat structures

  • Cloning and Expression:

    • Clone the MPN_285 gene into appropriate expression vectors

    • Consider using an E. coli expression system with codon optimization for mycoplasma genes

    • Add affinity tags (His, GST, or MBP) to facilitate purification

    • Express at lower temperatures (16-25°C) to enhance proper folding of this complex protein

  • Protein Purification:

    • Employ affinity chromatography as the initial purification step

    • Follow with size exclusion chromatography to separate properly folded protein

    • Consider ion exchange chromatography for final purification

    • Verify protein integrity through SDS-PAGE and Western blotting

  • Functional Characterization:

    • Perform DNA binding assays to assess specificity

    • Evaluate protein-protein interactions with other R-M system components

    • Use circular dichroism to analyze secondary structure, particularly important for repeat-containing proteins

    • Consider X-ray crystallography or cryo-EM for structural determination

How can researchers effectively analyze the amino acid sequence variations in MPN_285?

To effectively analyze amino acid sequence variations in MPN_285, researchers should implement the following methodological approaches:

  • Multiple Sequence Alignment (MSA):

    • Utilize specialized alignment tools that handle repeat regions effectively (e.g., MAFFT with the E-INS-i algorithm)

    • Translate nucleotide sequences to amino acids before alignment to better visualize functional changes

    • Focus particularly on the tandem repeat regions and their flanking sequences

    • Generate visual representations of alignments highlighting the "TELS" repeat patterns

  • Tandem Repeat Analysis:

    • Employ specialized tools like XSTREAM or Tandem Repeats Finder to identify and characterize repeat units

    • Quantify the number of repeat units in each strain

    • Correlate repeat numbers with phenotypic characteristics (especially macrolide resistance)

    • Analyze the conservation of repeat unit sequences across strains

  • Structural Prediction:

    • Use protein modeling tools like AlphaFold or SWISS-MODEL to predict structural implications of repeat variations

    • Focus on how repeat numbers might affect domain organization and protein folding

    • Analyze potential binding interfaces that might be affected by repeat variations

    • Compare predictions for resistant and susceptible variants

  • Evolutionary Analysis:

    • Calculate selection pressures on different regions of the protein

    • Determine if repeat regions are under positive, negative, or neutral selection

    • Construct phylogenetic trees based on MPN_285 sequences to understand evolutionary relationships

    • Compare evolutionary patterns with known antibiotic usage patterns in different geographical regions

What bioinformatics tools are recommended for studying structural changes in MPN_285?

For studying structural changes in MPN_285, researchers should utilize the following bioinformatics tools and approaches:

  • Sequence Analysis Tools:

    • BLAST for initial homology searches and identifying related proteins

    • MUSCLE or MAFFT for multiple sequence alignment, with special parameters for handling repeat regions

    • MEGA or PHYLIP for phylogenetic analysis to understand evolutionary relationships

    • XSTREAM, Tandem Repeats Finder, or TRUST for specialized tandem repeat identification and classification

  • Structural Prediction Tools:

    • AlphaFold or RoseTTAFold for accurate protein structure prediction

    • SWISS-MODEL for homology-based modeling if suitable templates exist

    • I-TASSER for integrative structure prediction combining multiple templates

    • MODELLER for custom modeling with constraints based on experimental data

  • Functional Prediction:

    • ProtParam for analyzing physicochemical properties

    • InterProScan for identifying functional domains and motifs

    • ConSurf for identifying conserved regions that may be functionally important

    • COACH or COFACTOR for ligand-binding site prediction

  • Visualization and Analysis:

    • PyMOL or UCSF Chimera for visualizing and analyzing predicted structures

    • VMD for molecular dynamics simulation visualization

    • EMBOSS suite for comprehensive sequence analysis

    • R or Python with BioPython/Pandas for custom analysis pipelines and data visualization

How does MPN_285 contribute to the pathogenesis of M. pneumoniae infections?

The contribution of MPN_285 to M. pneumoniae pathogenesis can be understood through several mechanisms:

  • Antibiotic Resistance Relationship: The clear association between MPN_285 tandem repeat patterns and macrolide resistance directly impacts pathogenesis by affecting treatment efficacy. Macrolide-resistant strains with distinctive MPN_285 patterns may persist despite antibiotic therapy, leading to prolonged infection and increased symptom severity .

  • Immune System Interaction: As part of the Type I R-M system, MPN_285 may influence how the bacterium responds to stress conditions, including host immune responses. The specificity protein may affect which genes are protected or restricted, potentially influencing virulence factor expression .

  • Genomic Plasticity Impact: The Type I R-M system, including MPN_285, controls genomic plasticity by regulating the acquisition of foreign DNA. This may affect the bacterium's ability to adapt to host environments or acquire new virulence traits .

  • Hydrogen Peroxide Production: While not directly linked in the available research, the pathogenesis of M. pneumoniae is known to be significantly dependent on hydrogen peroxide production (as seen with GlpQ and GlpD proteins). Any indirect effects of MPN_285 variations on metabolic pathways could potentially influence this virulence mechanism .

What challenges exist in studying MPN_285 mutations and how can they be overcome?

Studying MPN_285 mutations presents several challenges that researchers must address:

MPN_285 Gene Length Comparison Between Susceptible and Resistant Strains

PhenotypeGene Length Range (bp)Median Length (bp)Reference Strain Length (bp)
Macrolide Susceptible1254-1374~13141290 (M129)
Macrolide ResistantCommonly 14461446N/A

This data demonstrates the consistent pattern of longer gene sequences in resistant strains compared to susceptible strains, with a difference of approximately 130 bp on average .

"TELS" Tandem Repeat Variations in MPN_285

Strain TypeNumber of "TELS" Repeat DeletionsExample Strains
Macrolide Susceptible6-1611-473 (6 deletions), 11-107 (16 deletions), 11-994 (16 deletions)
Macrolide Resistant0All resistant strains maintain complete repeats

This table illustrates the stark contrast in tandem repeat patterns between susceptible and resistant strains, with susceptible strains showing variable numbers of deletions and resistant strains maintaining all repeats intact .

How can researchers effectively design primers for PCR amplification of MPN_285?

Effective primer design for PCR amplification of MPN_285 requires careful consideration of several factors:

  • Flanking Region Selection:

    • Design primers in conserved regions flanking the variable tandem repeat sections

    • Analyze multiple strain sequences to identify regions with >99% conservation

    • Position primers at least 50-100 bp away from the start/end of the tandem repeat region

    • Consider including restriction sites for subsequent cloning applications

  • Primer Characteristics:

    • Design primers with:

      • Length: 18-30 nucleotides

      • GC content: 40-60%

      • Melting temperature: 55-65°C with <5°C difference between pairs

      • No secondary structures or self-complementarity

    • Check for specificity against the entire M. pneumoniae genome to avoid off-target amplification

  • Tandem Repeat Considerations:

    • For sequencing the exact number of repeats, design primers that generate amplicons of manageable size (500-1500 bp)

    • For rapid screening of repeat numbers, design fluorescently labeled primers and use fragment analysis

    • Consider nested PCR approaches for improved specificity when working with clinical samples

  • PCR Optimization:

    • Use high-fidelity polymerases specifically designed for GC-rich templates

    • Include PCR additives like DMSO (5-10%) or betaine to reduce secondary structure formation

    • Implement touchdown PCR protocols to enhance specificity

    • Test amplification efficiency on control templates with known repeat numbers

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.